Association between Helicobacter pylori status and metachronous gastric cancer after endoscopic resection
- PMID: 27956803
- PMCID: PMC5124984
- DOI: 10.3748/wjg.v22.i44.9794
Association between Helicobacter pylori status and metachronous gastric cancer after endoscopic resection
Abstract
Aim: To investigate the effect of Helicobacter pylori (H. pylori) status test and H. pylori eradication on the occurrence of metachronous gastric cancer (MGC) after endoscopic submucosal dissection (ESD) of early gastric cancer (EGC) and risk factors of MGC.
Methods: The authors retrospectively reviewed the medical records of 433 patients (441 lesions) who underwent ESD for EGC from January 2005 to January 2015 in Yeungnam University Hospital. Patients were categorized into two groups; the H. pylori tested group (n = 257) and the H. pylori non-tested group (n = 176) based on performance of H. pylori status test after ESD of EGC. The H. pylori tested group was further categorized into three subgroups based on H. pylori status; the H. pylori-eradicated subgroup (n = 120), the H. pylori-persistent subgroup (n = 42), and the H. pylori-negative subgroup (n = 95). Incidences of MGC and risk factors of MGC were identified.
Results: Median follow-up duration after ESD was 30.00 mo (range, 6-107 mo). Total 15 patients developed MGC during follow-up. MGC developed in 11 patients of the H. pylori tested group (7 in the H. pylori-negative subgroup, 3 in the H. pylori-eradicated subgroup, and 1 in the H. pylori-persistent subgroup) and 4 patients of the H. pylori non-tested group (P > 0.05). The risk factors of MGC were endoscopic mucosal atrophy in the H. pylori tested group and intestinal metaplasia in all patients.
Conclusion: H. pylori eradication and H. pylori status test seems to have no preventive effect on the development of MGC after ESD for EGC. The risk factors of MGC development were endoscopic mucosal atrophy in the H. pylori tested group alone and intestinal metaplasia in all patients.
Keywords: Endoscopic submucosal dissection; Helicobacter pylori; Metachronous gastric cancer.
Conflict of interest statement
Conflict-of-interest statement: We have no conflict-of-interest to disclose.
Figures
Similar articles
-
Helicobacter pylori Eradication Prevents Metachronous Gastric Neoplasms after Endoscopic Resection of Gastric Dysplasia.PLoS One. 2015 Nov 18;10(11):e0143257. doi: 10.1371/journal.pone.0143257. eCollection 2015. PLoS One. 2015. PMID: 26580072 Free PMC article.
-
Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan.Gastric Cancer. 2016 Jul;19(3):911-8. doi: 10.1007/s10120-015-0544-6. Epub 2015 Sep 29. Gastric Cancer. 2016. PMID: 26420267
-
Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection.Aliment Pharmacol Ther. 2017 Oct;46(8):758-767. doi: 10.1111/apt.14263. Epub 2017 Aug 11. Aliment Pharmacol Ther. 2017. PMID: 28799258
-
Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of Helicobacter pylori Eradication and Aspirin.Gut Liver. 2020 May 15;14(3):281-290. doi: 10.5009/gnl19079. Gut Liver. 2020. PMID: 31547640 Free PMC article. Review.
-
Management of Helicobacter pylori infection after gastric surgery.World J Gastroenterol. 2014 May 14;20(18):5274-82. doi: 10.3748/wjg.v20.i18.5274. World J Gastroenterol. 2014. PMID: 24833857 Free PMC article. Review.
Cited by
-
Factors influencing occurrence of metachronous gastric cancer after endoscopic resection: a systematic review and meta-analysis.Korean J Intern Med. 2023 Nov;38(6):831-843. doi: 10.3904/kjim.2023.184. Epub 2023 Nov 1. Korean J Intern Med. 2023. PMID: 37939666 Free PMC article.
-
Individualized Endoscopic Surveillance for Metachronous Gastric Cancer After Endoscopic Submucosal Dissection: A Retrospective Observational Study.Turk J Gastroenterol. 2023 Jul;34(7):728-735. doi: 10.5152/tjg.2023.22655. Turk J Gastroenterol. 2023. PMID: 37232464 Free PMC article.
-
Helicobacter pylori eradication following endoscopic resection might prevent metachronous gastric cancer: a systematic review and meta-analysis of studies from Japan and Korea.Front Med (Lausanne). 2024 Sep 2;11:1393498. doi: 10.3389/fmed.2024.1393498. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39286646 Free PMC article.
-
Clinical outcomes of metachronous recurrence of gastric epithelial neoplasia based on Helicobacter pylori infection status and microsatellite stability.Korean J Intern Med. 2022 Jul;37(4):768-776. doi: 10.3904/kjim.2021.229. Epub 2022 May 4. Korean J Intern Med. 2022. PMID: 35508936 Free PMC article.
-
Chemoprevention of gastric cancer development after Helicobacter pylori eradication therapy in an East Asian population: Meta-analysis.World J Gastroenterol. 2020 Apr 21;26(15):1820-1840. doi: 10.3748/wjg.v26.i15.1820. World J Gastroenterol. 2020. PMID: 32351296 Free PMC article.
References
-
- Isomoto H, Shikuwa S, Yamaguchi N, Fukuda E, Ikeda K, Nishiyama H, Ohnita K, Mizuta Y, Shiozawa J, Kohno S. Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut. 2009;58:331–336. - PubMed
-
- Soetikno R, Kaltenbach T, Yeh R, Gotoda T. Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol. 2005;23:4490–4498. - PubMed
-
- Kwon YH, Heo J, Lee HS, Cho CM, Jeon SW. Failure of Helicobacter pylori eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patients. Aliment Pharmacol Ther. 2014;39:609–618. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous